Low expression of RORα leads to high circulating tumor cell count and up-regulation of VEGF in GC, while silencing RORα can significantly promote the proliferation, up-regulate N-cadherin and Vimentin, and down-regulate E-cadherin. The gene discussed is CDH2; the disease is gastric cancer.